Olaf Hardt

Company: Miltenyi Biotec

Job title: Senior Manager R&D

Seminars:

Identification of Target Candidates for Pancreatic Adenocarcinoma Immunotherapy 11:00 am

Miltenyi Biotec has combined high-throughput flow cytometry with a novel highcontent cyclic immunofluorescence instument “MACSima” for the early identification of target candidates for cellular immunotherapy Learn how MICS technology enables you to visualise hundreds of markers from fixed tissue to lift your sample analysis to the next level Get insights on our recent scientific findings…Read more

day: Day Two